A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

JF Baurain, N Meheust, S Monnoyer-Favrel… - Breast cancer research …, 2011 - Springer
Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids class
active in advanced stage breast cancer. We conducted a phase I study combining VFL with …

[PDF][PDF] A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer.

K Zaman, X Durando, JF Baurain, Y Humblet… - … Cancer Research and …, 2011 - serval.unil.ch
Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids class
active in advanced stage breast cancer. We conducted a phase I study combining VFL with …

[引用][C] A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

K ZAMAN, X DURANDO, JF BAURAIN… - Breast cancer …, 2011 - pascal-francis.inist.fr
A phase I clinical and pharmacological study evaluating vinflunine in combination with
doxorubicin as first line treatment in metastatic breast cancer CNRS Inist Pascal-Francis …

[PDF][PDF] A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

K Zaman, X Durando, JF Baurain, Y Humblet… - Breast Cancer Res …, 2011 - core.ac.uk
Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids class
active in advanced stage breast cancer. We conducted a phase I study combining VFL with …

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer.

K Zaman, X Durando, JF Baurain, Y Humblet… - … cancer research and …, 2011 - folia.unifr.ch
English Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids
class active in advanced stage breast cancer. We conducted a phase I study combining VFL …

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

K Zaman, X Durando, JF Baurain, Y Humblet… - … Cancer Research and …, 2011 - go.gale.com
Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids class
active in advanced stage breast cancer. We conducted a phase I study combining VFL with …

[HTML][HTML] A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

K Zaman, X Durando, JF Baurain… - … Cancer Research and …, 2011 - dial.uclouvain.be
Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids class
active in advanced stage breast cancer. We conducted a phase I study combining VFL with …

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

K Zaman, X Durando, JF Baurain, Y Humblet… - … Cancer Research and …, 2011 - doc.rero.ch
Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids class
active in advanced stage breast cancer. We conducted a phase I study combining VFL with …

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

K Zaman, X Durando, J Baurain… - Breast Cancer …, 2011 - search.proquest.com
Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids class
active in advanced stage breast cancer. We conducted a phase I study combining VFL with …

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer.

K Zaman, X Durando, JF Baurain… - … Cancer Research and …, 2011 - europepmc.org
Vinfunine (VFL) is a novel bifluorinated tubulin-targeted agent of the vinca alkaloids class
active in advanced stage breast cancer. We conducted a phase I study combining VFL with …